by Steven A. Grossman | Feb 23, 2025 | Short Takes and Updates
Information for Reporters[1] Note: Since the original column was published, I have become aware that lay-offs should not be referred to as a reduction-in-force (RIF) because that term triggers certain procedures and protections that employees might not have in the...
by Steven A. Grossman | Feb 20, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. FDA At Risk on Four FrontsAll the federal public health programs are under siege. While my focus is on FDA, I want readers to know that NIH and CDC...
by Steven A. Grossman | Feb 18, 2025 | Short Takes and Updates
FDA employees—public-spirited and committed—are the heart of the agency and can proudly point to a lengthy record of accomplishment. Our country has safe food and safe and effective medical products because of their efforts. We are all affected: every American uses...
by Steven A. Grossman | Feb 14, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. When Will Congress Engage on the Future of FDA User Fees?Either the agency is captured by industry (Secretary Kennedy), or it is a hindrance to...
by Steven A. Grossman | Feb 12, 2025 | Short Takes and Updates
Permission is granted to reprint or recirculate this column, as long as attribution is made to FDA Matters (www.fdamatters.com) and the author. “A cynic knows the price of everything and the value of nothing.”—Oscar WildePart 1: Meaningful Deficit...
